These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 36357367)

  • 1. Muscular Swedish mutant APP-to-Brain axis in the development of Alzheimer's disease.
    Pan JX; Lee D; Sun D; Zhao K; Xiong L; Guo HH; Ren X; Chen P; Lopez de Boer R; Lu Y; Lin H; Mei L; Xiong WC
    Cell Death Dis; 2022 Nov; 13(11):952. PubMed ID: 36357367
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Osteoblastic Swedish mutant APP expedites brain deficits by inducing endoplasmic reticulum stress-driven senescence.
    Pan JX; Sun D; Lee D; Xiong L; Ren X; Guo HH; Yao LL; Lu Y; Jung C; Xiong WC
    Commun Biol; 2021 Nov; 4(1):1326. PubMed ID: 34824365
    [TBL] [Abstract][Full Text] [Related]  

  • 3. APP in the Neuromuscular Junction for the Development of Sarcopenia and Alzheimer's Disease.
    Wu MY; Zou WJ; Lee D; Mei L; Xiong WC
    Int J Mol Sci; 2023 Apr; 24(9):. PubMed ID: 37175515
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Swedish mutant APP suppresses osteoblast differentiation and causes osteoporotic deficit, which are ameliorated by N-acetyl-L-cysteine.
    Xia WF; Jung JU; Shun C; Xiong S; Xiong L; Shi XM; Mei L; Xiong WC
    J Bone Miner Res; 2013 Oct; 28(10):2122-35. PubMed ID: 23649480
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Swedish mutant APP-based BACE1 binding site peptide reduces APP β-cleavage and cerebral Aβ levels in Alzheimer's mice.
    Li S; Hou H; Mori T; Sawmiller D; Smith A; Tian J; Wang Y; Giunta B; Sanberg PR; Zhang S; Tan J
    Sci Rep; 2015 Jun; 5():11322. PubMed ID: 26091071
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative studies using the Morris water maze to assess spatial memory deficits in two transgenic mouse models of Alzheimer's disease.
    Edwards SR; Hamlin AS; Marks N; Coulson EJ; Smith MT
    Clin Exp Pharmacol Physiol; 2014 Oct; 41(10):798-806. PubMed ID: 25115283
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Swedish dilemma - the almost exclusive use of APPswe-based mouse models impedes adequate evaluation of alternative β-secretases.
    Armbrust F; Bickenbach K; Marengo L; Pietrzik C; Becker-Pauly C
    Biochim Biophys Acta Mol Cell Res; 2022 Mar; 1869(3):119164. PubMed ID: 34699873
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intermittent hypoxia treatment alleviates memory impairment in the 6-month-old APPswe/PS1dE9 mice and reduces amyloid beta accumulation and inflammation in the brain.
    Yue X; Zhou Y; Qiao M; Zhao X; Huang X; Zhao T; Cheng X; Fan M; Zhao Y; Chen R; Zhu L
    Alzheimers Res Ther; 2021 Nov; 13(1):194. PubMed ID: 34844651
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Amyloid precursor protein processing and retinal pathology in mouse models of Alzheimer's disease.
    Dutescu RM; Li QX; Crowston J; Masters CL; Baird PN; Culvenor JG
    Graefes Arch Clin Exp Ophthalmol; 2009 Sep; 247(9):1213-21. PubMed ID: 19271231
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Amyloid-β plaque formation and reactive gliosis are required for induction of cognitive deficits in App knock-in mouse models of Alzheimer's disease.
    Sakakibara Y; Sekiya M; Saito T; Saido TC; Iijima KM
    BMC Neurosci; 2019 Mar; 20(1):13. PubMed ID: 30894120
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Detrimental Effects of Centrally Administered Angiotensin II are Enhanced in a Mouse Model of Alzheimer Disease Independently of Blood Pressure.
    Takane K; Hasegawa Y; Lin B; Koibuchi N; Cao C; Yokoo T; Kim-Mitsuyama S
    J Am Heart Assoc; 2017 Apr; 6(4):. PubMed ID: 28428194
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular systems evaluation of oligomerogenic APP(E693Q) and fibrillogenic APP(KM670/671NL)/PSEN1(Δexon9) mouse models identifies shared features with human Alzheimer's brain molecular pathology.
    Readhead B; Haure-Mirande JV; Zhang B; Haroutunian V; Gandy S; Schadt EE; Dudley JT; Ehrlich ME
    Mol Psychiatry; 2016 Aug; 21(8):1099-111. PubMed ID: 26552589
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative studies of glial fibrillary acidic protein and brain-derived neurotrophic factor expression in two transgenic mouse models of Alzheimer's disease.
    Edwards SR; Khan N; Coulson EJ; Smith MT
    Clin Exp Pharmacol Physiol; 2020 Oct; 47(10):1740-1750. PubMed ID: 32542833
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of accelerated senescence on learning and memory, locomotion and anxiety-like behavior in APP/PS1 mouse model of Alzheimer's disease.
    Lok K; Zhao H; Zhang C; He N; Shen H; Wang Z; Zhao W; Yin M
    J Neurol Sci; 2013 Dec; 335(1-2):145-54. PubMed ID: 24095271
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Amyloid deposition and inflammation in APPswe/PS1dE9 mouse model of Alzheimer's disease.
    Ruan L; Kang Z; Pei G; Le Y
    Curr Alzheimer Res; 2009 Dec; 6(6):531-40. PubMed ID: 19747158
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intranasal interferon beta improves memory and modulates inflammatory responses in a mutant APP-overexpressing rat model of Alzheimer's disease.
    Chavoshinezhad S; Mohseni Kouchesfahani H; Salehi MS; Pandamooz S; Ahmadiani A; Dargahi L
    Brain Res Bull; 2019 Aug; 150():297-306. PubMed ID: 31233762
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Citalopram restores short-term memory deficit and non-cognitive behaviors in APP/PS1 mice while halting the advance of Alzheimer's disease-like pathology.
    Zhang Q; Yang C; Liu T; Liu L; Li F; Cai Y; Lv K; Li X; Gao J; Sun D; Xu H; Yang Q; Fan X
    Neuropharmacology; 2018 Mar; 131():475-486. PubMed ID: 29241655
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Imbalance of Microglial TLR4/TREM2 in LPS-Treated APP/PS1 Transgenic Mice: A Potential Link Between Alzheimer's Disease and Systemic Inflammation.
    Zhou J; Yu W; Zhang M; Tian X; Li Y; Lü Y
    Neurochem Res; 2019 May; 44(5):1138-1151. PubMed ID: 30756214
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inflammatory Chemokines Expression Variations and Their Receptors in APP/PS1 Mice.
    Jorda A; Aldasoro M; Aldasoro C; Valles SL
    J Alzheimers Dis; 2021; 83(3):1051-1060. PubMed ID: 34397415
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Outstanding Phenotypic Differences in the Profile of Amyloid-β between Tg2576 and APPswe/PS1dE9 Transgenic Mouse Models of Alzheimer's Disease.
    Allué JA; Sarasa L; Izco M; Pérez-Grijalba V; Fandos N; Pascual-Lucas M; Ogueta S; Pesini P; Sarasa M
    J Alzheimers Dis; 2016 May; 53(3):773-85. PubMed ID: 27258422
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.